IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q1 2018 Holdings

Filed 2018-05-15 | 4 holdings | $169.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$85.4K8,930,23750.3%
Inflarx NV(IFRX)COMN44821101$54.1K1,876,41331.9%
Marinus Pharmaceuticals IncCOM56854Q101$15.2K3,977,4539.0%
Solid Biosciences IncCOM83422E105$14.9K1,989,4448.8%